Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats

Translational Research

Volumn 156, Issue 5, 2010, Pages 282-291

  Kono, Hiroshi ^a   Fujii, Hideki ^a   Ogiku, Masahito ^a   Tsuchiya, Masato ^a   Ishii, Kenichi ^a   Hara, Michio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHEMOKINE; CYTOKINE; ENEMA; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN; MEDIUM CHAIN TRIACYLGLYCEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ENDOTOXIN; PEROXIDASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RAT; WISTAR RAT; ANIMAL; ANIMAL FOOD; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENDOTOXEMIA; ENTERIC FEEDING; ENZYMOLOGY; METABOLISM; PATHOLOGY; PROCEDURES; TOXICITY;

ANIMAL FEED; ANIMALS; BODY WEIGHT; CHEMOKINES; COLITIS; COLON; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; ENEMA; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; MALE; PEROXIDASE; RATS; RATS, WISTAR; TRIGLYCERIDES; TRINITROBENZENESULFONIC ACID;

EID: 77958523704     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.07.012     Document Type: Article

References (36)

1. F.A. Farraye, R.D. Odze, J. Eaden, and S.H. Itzkowitz AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 746 774
2. S. Larsen, K. Bendtzen, and O.H. Nielsen Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management Ann Med 42 2010 97 114
3. G.R. Lichtenstein, M.T. Abreu, R. Cohen, and W. Tremaine American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease Gastroenterology 130 2006 940 987 (Pubitemid 43374543)
4. F. Shanahan Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics Gastroenterology 120 2001 622 635
5. R. Razack, and D.L. Seidner Nutrition in inflammatory bowel disease Curr Opin Gastroenterol 23 2007 400 405
6. A.J. Lucendo, and L.C. De Rezende Importance of nutrition in inflammatory bowel disease World J Gastroenterol 15 2009 2081 2088
7. D. Jonkers, and R. Stockbrugger Review article: probiotics in gastrointestinal and liver diseases Aliment Pharmacol Ther 26 2007 133 148
8. F. Guarner Prebiotics in inflammatory bowel diseases Br J Nutr 98 2007 S85 S89
9. H. Kono, H. Fujii, and M. Asakawa Protective effects of medium-chain triglycerides on the liver and the gut in rats administered endotoxin Ann Surg 237 2003 246 255
10. H. Kono, H. Fujii, and M. Asakawa Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin Am J Physiol Gastrointest Liver Physiol 286 2004 G1081 G1089
11. L. Caradonna, L. Amati, T. Magrone, N.M. Pellegrino, E. Jirillo, and D. Caccavo Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance J Endotoxin Res 6 2000 205 214
12. H. Kono, H. Fujii, K. Ishii, N. Hosomura, and M. Ogiku Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats Transl Res 155 2010 131 141
13. T. Sakurai, T. Matsui, and T. Yao Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas JPEN J Parenter Enteral Nutr 26 2002 98 103
14. A. Andoh, T. Tsujikawa, and I. Ishizuka N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis Int J Mol Med 12 2003 721 725
15. S. Sou, T. Sakurai, and T. Matsui Short-term efficacy of a polymeric formula (RacolR) in the treatment of active Crohns disease Nippon Daicho Komonbyo Gakkai Zasshi 61 2008 509 515
16. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
17. B.R. MacPherson, and C.J. Pfeiffer Experimental production of diffuse colitis in rats Digestion 17 1978 135 150
18. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
19. H. Kono, M.D. Wheeler, and I. Rusyn Gender differences in early alcohol-induced liver injury: role of CD14, NF-κB and TNF-α Am J Physiol 278 2000 G652 G661
20. C.A. Rivera, and R.G. Thurman Tips for measuring endotoxin in plasma Alcohol Clin Exp Res 22 1998 2192 2194
21. N. Sakamoto, S. Kono, and K. Wakai Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan Inflamm Bowel Dis 11 2005 154 163
22. R. Shoda, K. Matsueda, S. Yamato, and N. Umeda Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease J Gastroenterol 30 1995 98 101
23. H. Kono, N. Enomoto, and H.D. Connor Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol Am J Physiol Gastrointest Liver Physiol 278 2000 G467 G476
24. T. Tsujikawa, N. Ohta, and T. Nakamura Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis J Gastroenterol 36 2001 673 680
25. D.D. Taub Chemokine-leukocyte interactions. The voodoo that they do so well Cytokine Growth Factor Rev 7 1996 355 376
26. C. Becker, H. Dornhoff, and C. Neufert Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis J Immunol 177 2006 2760 2764
27. P. Garside Cytokines in experimental colitis Clin Exp Immunol 118 1999 337 339
28. M.F. Neurath, I. Fuss, and M. Pasparakis Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice Eur J Immunol 27 1997 1743 1750
29. K. Harada, A. Toyonaga, K. Mitsuyama, E. Sasaki, and K. Tanikawa Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis Digestion 55 1994 179 184
30. C.O. Elson, R.B. Sartor, G.S. Tennyson, and R.H. Riddell Experimental models of inflammatory bowel disease Gastroenterology 109 1995 1344 1367
31. P. Damas, D. Ledoux, and M. Nys Cytokine serum level during severe sepsis in human IL-6 as a marker of severity Ann Surg 215 1992 356 362
32. T. Pritts, E. Hungness, Q. Wang, B. Robb, D. Hershko, and P.O. Hasselgren Mucosal and enterocyte IL-6 production during sepsis and endotoxemia - role of transcription factors and regulation by the stress response Am J Surg 183 2002 372 383
33. E.P. Molmenti, T. Ziambaras, and D.H. Perlmutter Evidence for an acute phase response in human epithelial cells J Biol Chem 268 1993 14116 14126
34. Q. Wang, J.E. Fischer, and P.O. Hasselgren Treatment of endotoxemic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis Arch Surg 132 1997 82 88
35. K.W. Beagley, J.H. Eldridge, and F. Lee Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells J Exp Med 169 1989 2133 2148
36. R.F. Grimble Immunonutrition Curr Opin Gastroenterol 21 2005 216 222